Evidence for opiate-activated NMDA processes masking opiate analgesia in rats

Brain Research

Volumn 847, Issue 1, 1999, Pages 18-25

  Célèrier, Evelyne ^a   Laulin, Jean Paul ^a   Larcher, Agnès ^a   Le Moal, Michel ^a   Simonnet, Guy ^a  

^a INSERM   (France)

Author keywords

Analgesia; Fentanyl; MK 801; Morphine; Naloxone precipitated hyperalgesia; NMDA pain facilitatory processes

Indexed keywords

DIZOCILPINE; FENTANYL; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; OPIATE; OPIATE RECEPTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FENTANYL; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NOCICEPTORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID;

EID: 0345035480     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01998-8     Document Type: Article

References (50)

1. Aanonsen L.M., Wilcox G.L. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J. Pharmacol. Exp. Ther. 243:1987;9-19215.
2. Advokat C., Rhein F.Q. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res. 699:1995;157-160.
3. Bederson J.B., Fields H.L., Barbaro N.M. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla. Somatosens. Mot. Res. 7:1990;185-203.
4. Bespalov A., Kudryashova M., Zvartau E. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats. Eur. J. Pharmacol. 351:1998;299-305.
5. Cappendijk S.L., de V.R., Dzoljic M.R. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Eur. Neuropsychopharmacol. 3:1993;111-116.
6. Celerier E., Bouhassira D., Le Bars D., Le Moal M., Simonnet G. The NMDA antagonist MK-801 enhances morphine-induced analgesia by blocking an opiate-activated NMDA facilitatory system of nociception. Soc. Neurosci. Abstr. 24:1998;1867.
7. Chapman V., Dickenson A.H. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res. 573:1992;321-323.
8. Chen L., Huang L.Y. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron. 7:1991;319-326.
9. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature. 356:1992;521-523.
10. Christensen D., Idanpaan-Heikkila J.J., Guilbaud G., Kayser V. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy. Br. J. Pharmacol. 125:1998;1641-1650.
11. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
12. Devillers J.P., Boisserie F., Laulin J.P., Larcher A., Simonnet G. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Res. 700:1995;173-181.
13. Dickenson A.H., Sullivan A.F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology. 26:1987;1235-1238.
14. Dickenson A.H., Sullivan A.F. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat. Brain Res. 506:1990;31-39.
15. R. Dubner, Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury, in: M.R. Bond, J.E. Charlton, C.J. Woolf, (Eds.), Pain Research and Clinical Management, Elsevier, Amsterdam, 1991, pp. 263-276.
16. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain. 56:1994;69-75.
17. Feng J., Kendig J.J. N-methyl-D-aspartate receptors are implicated in hyperresponsiveness following naloxone reversal of alfentanil in isolated rat spinal cord. Neurosci. Lett. 189:1995;128-130.
18. Feng J., Kendig J.J. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro. Pain. 66:1996;343-349.
19. Goldfarb J., Kaplan E.I., Jenkins H.R. Interaction of morphine and naloxone in acute spinal cats. Neuropharmacology. 17:1978;569-575.
20. Grilly D.M., Gowans G.C. Acute morphine dependence: effects observed in shock and light discrimination tasks. Psychopharmacology (Berlin). 88:1986;500-504.
21. J.E. Haley, G.L. Wilcox, Involvement of excitatory amino acids and peptides in the spinal mechanisms underlying hyperalgesia, in: W.D. Willis (Ed.), Hyperalgesia and Allodynia, Raven Press, New York, 1992, pp. 281-293.
22. Hoffmann O., Wiesenfeld-Hallin Z. Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats. NeuroReport. 7:1996;838-840.
23. Honore P., Chapman V., Buritova J., Besson J.M. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression. Anesthesiology. 85:1996;150-160.
24. Jhamandas K.H., Marsala M., Ibuki T., Yaksh T.L. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine. J. Neurosci. 16:1996;2758-2766.
25. Kayan S., Woods L.A., Mitchell C.L. Morphine-induced hyperalgesia in rats tested on the hot plate. J. Pharmacol. Exp. Ther. 177:1971;509-513.
26. Kayser V., Guilbaud G. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats. Pain. 41:1990;353-363.
27. Kim D.H., Fields H.L., Barbaro N.M. Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes. Brain Res. 516:1990;37-40.
28. Koob G.F. Drug addiction: the yin and yang of hedonic homeostasis. Neuron. 16:1996;893-896.
29. Larcher A., Laulin J.P., Celerier E., Le Moal M., Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience. 84:1998;583-589.
30. Laulin J.P., Larcher A., Celerier E., Le Moal M., Simonnet G. Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur. J. Neurosci. 10:1998;782-785.
31. Le Bars D., Guilbaud G., Jurna I., Besson J.M. Differential effects of morphine on responses of dorsal horn lamina V type cells elicited by A and C fibre stimulation in the spinal cat. Brain Res. 115:1976;518-524.
32. Lipa S.M., Kavaliers M. Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia. Brain Res. Bull. 24:1990;627-630.
33. Lutfy K., Hurlbut D.E., Weber E. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616:1993;83-88.
34. Ma Q.P., Woolf C.J. Noxious stimuli induce an N-methyl-D-aspartate receptor-dependent hypersensitivity of the flexion withdrawal reflex to touch: implications for the treatment of mechanical allodynia. Pain. 61:1995;383-390.
35. Manning B.H., Mao J., Frenk H., Price D.D., Mayer D.J. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain. 67:1996;79-88.
36. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14:1994;2301-2312.
37. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
38. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
39. Martin W.R., Gilbert P.E., Jasinski D.R., Martin C.D. An analysis of naltrexone precipitated abstinence in morphine-dependent chronic spinal dogs. J. Pharmacol. Exp. Ther. 240:1987;565-570.
40. Popik P., Mamczarz J., Fraczek M., Widla M., Hesselink M., Danysz W. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology. 37:1998;1033-1042.
41. Saucier D.M., Kavaliers M. Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice. Brain Res. 637:1994;292-296.
42. Solomon R.L. The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am. Psychol. 35:1980;691-712.
43. Stevens C.W., Yaksh T.L. Magnitude of opioid dependence after continuous intrathecal infusion of mu- and delta-selective opioids in the rat. Eur. J. Pharmacol. 166:1989;467-472.
44. Stiller H., Gustafsson H., Bergquist J. Morphine induced release of GABA, glycine and glutamate in the dorsal horn of the spinal cord in anaesthetized rats. Soc. Neurosci. Abstr. 24:1998;886.
45. Tilson H.A., Rech R.H., Stolman S. Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia. 28:1973;287-300.
46. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
47. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes? Drugs. 55:1998;1-4.
48. G.L. Wilcox, Excitatory neurotransmitters and pain, in: M.R. Bond, J.E. Charlton, C.J. Woolf (Eds.), Proc. VIth World Congress on Pain, IASP, Seattle, 1991, pp. 97-117.
49. Wilcox R.E., Mikula J.A., Levitt R.A. Periaqueductal gray naloxone microinjections in morphine-dependent rats: hyperalgesia without "classical" withdrawal. Neuropharmacology. 18:1979;639-641.
50. Woolf C.J., Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.